White Ginseng Extract

Main Active Ingredients:
Total Ginsenosides – CAS: 90045-38-8|Assay: 10% ,30%,80% total ginsenosides (HPLC)| 10:1 or 20:1 concentrate
Application: dietary supplements, cognitive-support & nootropic formulations, functional foods & beverages, cosmeceutical actives
MOQ: 1KG|US Warehouse Stock Available — ships within 2 business days for US customers
Certifications: ISO, HACCP, GMP, Kosher, Halal, Organic, BRC, FDA Registered Facility

Thank you for sharing our article through the button

Facebook
X
LinkedIn
Telegram
Reddit

White Ginseng Extract (Panax ginseng): Standardized Ginsenosides Rb1 & Rg1 — B2B Wholesale Supplier

Written by Jonathan, Valeherb · Reviewed by Dr. Xiaoyan Qiu · Updated June 2026

White ginseng extract preserves the native ginsenoside profile of Panax ginseng C.A. Meyer root through air-drying without heat processing — retaining the full-spectrum Rb1 and Rg1 content that is the focus of most published research on ginseng’s adaptogenic, cognitive, and immune-related activity. Valeherb supplies white ginseng extract in five B2B specifications: 10% total ginsenosides, 30% total ginsenosides, 80% total ginsenosides, 10:1 concentrate, and 20:1 concentrate — covering formulation requirements from functional food to high-purity nutraceutical and pharmaceutical-use manufacturing.


Active Compounds: Why the Native Ginsenoside Profile Matters

White ginseng retains the naturally occurring balance of ginsenosides as they exist in the fresh root. The two dominant and most extensively researched compounds are:

Ginsenoside Class Primary Activity Studied in Research
Rb1 Protopanaxadiol (PPD) Neuroprotective activity via Nrf2 antioxidant pathway; memory consolidation; anti-fatigue; calming CNS modulation[3]
Rg1 Protopanaxatriol (PPT) Cognitive support; HPA axis stress modulation; inflammatory-pathway signaling (Nrf2/HO-1)[2]

Rb1 and Rg1 together account for the majority of white ginseng’s researched compound profile. Their complementary mechanisms — Rb1 associated with calming neuroprotection, Rg1 with stimulatory cognitive support — produce the balanced adaptogenic effect that has informed ginseng’s traditional and research use over decades.[3]

KEY POINT
White ginseng is not a lesser alternative to red ginseng — it is a distinct specification for distinct applications. Red ginseng’s steaming process converts Rb1 and Rg1 into Rg3 and other rare ginsenosides with different activity profiles. White ginseng preserves Rb1 and Rg1 at their highest natural concentrations, making it the preferred specification for formulations where native ginsenoside ratios and clean-label positioning are the priority. Valeherb supplies both; the right choice depends on your target claim and formulation context.

Research-Documented Activity Areas

NOTE
The research summarised below characterises the bioactivity of ginsenosides and is provided for informational purposes only. It is not a claim for any specific Valeherb product or finished good. Any claim on a finished supplement is the marketer’s responsibility to substantiate under applicable regulations.

1. Memory & Cognitive Support

A 2024 systematic review and meta-analysis by Zeng et al. covering 15 RCTs and 671 participants reported a statistically significant improvement in memory outcomes with ginseng supplementation (SMD = 0.19, 95% CI: 0.02–0.36, p < 0.05), with stronger effects at higher doses (SMD = 0.33 at high dose).[1] Memory is the most consistently supported cognitive endpoint across the ginseng clinical literature, which makes it the most defensible basis for a structure/function claim — though any finished-product claim remains the marketer’s responsibility to substantiate.

2. Adaptogenic Stress Modulation

Ginsenosides Rb1 and Rg1 have been studied for interaction with glucocorticoid receptors and modulation of HPA axis activity — a core mechanism associated with adaptogenic stress protection. Preclinical research indicates both compounds activate Nrf2-mediated antioxidant defense, protecting neuronal cells from oxidative stress-induced damage.[3][4] In research, this mechanism is associated with physical recovery, fatigue reduction, and stress resilience — without the stimulant profile of caffeine-based alternatives.

3. Inflammatory-Pathway & Immune Research

Rg1 has been studied for inflammatory-pathway activity via Nrf2/HO-1 signaling, including effects on pro-inflammatory cytokine expression.[2] Combined with Rb1’s antioxidant activity, these are research areas relevant to immune-support and seasonal-wellness formulation categories.


Available Specifications

Specification Ginsenoside Content Recommended Application
10% Total Ginsenosides 10% by HPLC General wellness supplements, functional foods, entry-level capsules and tablets, herbal blends where a standard supplement-grade marker is specified
30% Total Ginsenosides 30% by HPLC Premium supplement capsules, nootropic stacks, functional beverage fortification
80% Total Ginsenosides 80% by HPLC High-purity supplement and pharmaceutical-use formulations, low-excipient capsules, cosmeceutical actives
10:1 Concentrate Standardized concentration ratio; HPLC fingerprint available General wellness supplements, functional foods, formulations specifying a traditional extract ratio
20:1 Concentrate Standardized concentration ratio; HPLC fingerprint available High-concentration capsules, cost-effective delivery of higher ginsenoside load per serving

Sourcing Criteria: What to Require from Any Supplier

Criterion What to Require
Ginsenoside Standardization HPLC-verified total ginsenoside content per batch — not UV spectrophotometry, which cannot distinguish individual ginsenosides
Rb1 / Rg1 Breakdown Individual quantification of Rb1 and Rg1 for premium applications — confirms native white ginseng profile and rules out adulteration or misrepresentation
Processing Verification Air-dried without steaming — request processing documentation confirming white ginseng specification. Rg3 presence on COA is a red flag for mislabeled red ginseng
Root Origin & Age Korean 6-year root is the most clinically validated source. Request origin documentation and root age certification
Third-Party COA Total ginsenosides (HPLC), heavy metals (USP <232>), pesticide residues, microbial limits (USP <2021>), moisture — per batch
Certifications Non-GMO, Kosher/Halal for relevant markets. FDA-registered facility required for US supplement supply chains
CAUTION
Not recommended during pregnancy or breastfeeding. Theoretical interactions with warfarin and MAO inhibitors reported — precautionary label disclosure recommended. High doses (>2 g/day) may cause insomnia or mild agitation in sensitive individuals. Individuals with hormone-sensitive conditions should consult a healthcare professional before use.

Regulatory Guidance

FDA NOTICE
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Required for all dietary supplement products sold in the United States.
  • US (DSHEA): Any structure/function claim on the finished product is the marketer’s responsibility to substantiate and must carry the FDA disclaimer; memory/cognitive support is the most strongly backed by published RCT and meta-analysis data. Disease treatment claims require drug (NDA) approval
  • EU: Panax ginseng root has a well-established use monograph under EMA/HMPC/321232/2012 supporting claims of temporary relief of stress symptoms and fatigue
  • Canada (NHPs): Licensed Health Canada monograph supporting cognitive function, physical performance, and immune support claims

References

[1] Zeng M et al. (2024). Effects of ginseng on cognitive function: a systematic review and meta-analysis. Phytotherapy Research, 38(12), 6023–6034. PMID: 39474788

[2] Liang HY et al. (2021). Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer’s disease. Aging, 13(5), 7769–7790. PMID: 33686024

[3] Fernández-Moriano C et al. (2017). Evaluation of the adaptogenic potential exerted by ginsenosides Rb1 and Rg1 against oxidative stress-mediated neurotoxicity in an in vitro neuronal model. PLOS ONE, 12(8), e0182933. PMID: 28813475

[4] Panossian A & Wikman G. (2010). Effects of adaptogens on the central nervous system and molecular mechanisms associated with their stress-protective activity. Pharmaceuticals, 3(1), 188–224. PMID: 27713248

FAQ

A1:They come from the same root but differ in processing, and the difference shows up directly on the COA. White ginseng is air-dried without heat, which preserves Rb1 and Rg1 at their highest natural concentrations. Red ginseng is steamed, which converts part of those ginsenosides into Rg3 and other rare forms with a different activity profile. Neither is “better” in the abstract — white ginseng is preferred where native Rb1/Rg1 ratios and clean-label positioning matter, while red ginseng is chosen when the Rg3-class profile is the target. If you order white ginseng and the COA shows significant Rg3, treat it as a red flag for mislabeled material.
A2:It depends on potency needs and cost structure. The 30% and 80% grades are standardized to a defined total-ginsenoside percentage by HPLC, so they give defensible, repeatable marker content; 30% suits premium capsules and beverage fortification, while 80% suits high-purity, low-excipient and cosmeceutical applications. The 10:1 and 20:1 concentrates are ratio extracts characterised by HPLC fingerprint rather than a fixed percentage, and are a cost-effective fit for general wellness supplements and functional foods. If your finished-product label needs to state a specific ginsenoside percentage, choose a standardized grade.
A3:Require HPLC quantification per batch rather than UV spectrophotometry, since UV cannot distinguish individual ginsenosides and is easier to game. For premium applications, ask for an individual Rb1 and Rg1 breakdown, not just total ginsenosides, which confirms the native white ginseng profile. Request processing documentation confirming the root was air-dried and not steamed, and check that the COA does not show an Rg3-dominant profile. Korean 6-year root is the most clinically validated origin, so origin and root-age documentation add further assurance.
A4:Marker content and published research support ingredient-level positioning, but any structure/function claim on the finished product is the marketer’s responsibility to substantiate and must carry the required FDA disclaimer in the US. Memory and cognitive support are the most strongly backed by RCT and meta-analysis data, making them the most defensible basis for a claim; disease treatment language requires drug (NDA) approval. The EU and Canada handle ginseng claims differently — both have established monographs — so confirm the framework for your target market

SEND INQUIRY

Contact Form Demo

The essence of natural sweetness — extracted directly from plants

The most promising sugar-free and zero-calorie sweetener usage guide for 2026

Understand the gap between natural sweeteners and synthetic sweeteners